Addressing challenges in patient recruitment for clinical trials

One of the main challenges in patient recruitment for clinical trials is meeting recruitment targets in terms of numbers and diversity.  Additional challenges sponsors meet are patient adherence and patient retention. We believe that recruiting patients into clinical trials requires patient trust and personalized, one-on-one interactions between the recruiter and the patient. These requirements may explain why despite great leaps, technology has been unable to overcome this significant hurdle to shortening clinical trial timelines, and current recruitment methods simply don’t work.

Our Precision Patient Recruitment is de-risking clinical trial operations from A-Z while cutting costs and ensuring Diversity, Equity, & Inclusion (DEI) compliance at the same time.

We do this with cutting-edge, adaptive, agile, AI-based technology, which we put in the right hands (community pharmacists) at the right time (matching them and their patients to the right trial).

How our precision patient recruitment services work

RxE2 Precision patient recruitment for clinical trials - how it works

Our precision patient recruitment services and technology address the main challenges in patient recruitment for clinical trials by referring pre-qualified, already consenting diverse patients to trial sites, ensuring sponsors meet their targets, and improving adherence and retention at the same time.

Read our Case Study

Precision patient recruitment for clinical trials: Cutting edge technology; spearheaded by community pharmacists

E2 Recruitment: Fast, High Quality and Diverse

RxE2’s unique Patient Recruitment services do more than use technology and data to enroll patients: they add a human touch from trusted medication experts. Using local, independent pharmacies across the United States and the world, RxE2 not only establishes a strong foundation upon which clinical researchers can conduct community-based and decentralized trials but also provides an opportunity for those who have never participated in a clinical trial, encompassing 85% of the population, to get involved.

Contact us to see how you can recruit more patients faster!